Compare DK & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DK | ATRC |
|---|---|---|
| Founded | 2001 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | 2006 | 2005 |
| Metric | DK | ATRC |
|---|---|---|
| Price | $28.43 | $39.39 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 16 | 9 |
| Target Price | $35.69 | ★ $52.22 |
| AVG Volume (30 Days) | ★ 1.4M | 472.4K |
| Earning Date | 02-24-2026 | 02-11-2026 |
| Dividend Yield | ★ 3.64% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,667,200,000.00 | $518,304,999.00 |
| Revenue This Year | N/A | $16.94 |
| Revenue Next Year | N/A | $12.54 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 15.80 |
| 52 Week Low | $11.03 | $28.29 |
| 52 Week High | $43.50 | $43.18 |
| Indicator | DK | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 38.78 | 49.88 |
| Support Level | $25.85 | $37.98 |
| Resistance Level | $31.00 | $41.80 |
| Average True Range (ATR) | 1.59 | 2.08 |
| MACD | 0.09 | -0.17 |
| Stochastic Oscillator | 44.48 | 47.05 |
Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has two segments: Refining segment and Logistics segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.